Inventor

Steven Read

Inventor
Denver, CO, US

Overview

116→
Patents
2009–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 116 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes28%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
A61KPreparations for medical, dental or toiletry purposes11%
C12YEnzymes10%
C07HSugars2%
C07KPeptides1%
G06FElectric digital data processing0%
PatentTitleYear
10,765,695Methods and compositions for selecting siRNA of improved functionality202010,696,968Methods and compositions for selecting siRNA of improved functionality202010,421,970Methods and compositions for selecting siRNA of improved functionality201910,233,449Methods and compositions for selecting siRNA of improved functionality201910,011,836Methods and compositions for selecting siRNA of improved functionality20189,879,266'Methods and compositions for selecting siRNA of improved functionality'20189,839,649'Methods and compositions for selecting siRNA of improved functionality'20179,777,270'Methods and compositions for selecting siRNA of improved functionality'20179,771,586'RNAi targeting ZNF205'20179,719,094'RNAi targeting SEC61G'20179,719,092'RNAi targeting CNTD2'20179,228,186'Methods and compositions for selecting siRNA of improved functionality'20168,937,172'siRNA targeting catenin, beta-1 (CTNNB1)'20158,907,077'siRNA targeting TIE-2'20148,883,998'siRNA targeting myeloid differentiation primary response gene (88) (MYD88)'20148,658,785'siRNA targeting tie-2'20148,658,784'siRNA targeting amyloid beta (A4) precursor protein (APP)'20148,633,306'SiRNA targeting histamine receptor H1'20148,575,329'siRNA targeting kinase insert domain receptor (KDR)'20138,461,326'SiRNA targeting connective tissue growth factor (CTGF)'20138,445,668'SiRNA targeting apolipoprotein (APOB)'20138,445,667'SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)'20138,426,579'SiRNA targeting myeloid differentiation primary response gene (88) (MYD88)'20138,399,654'siRNA targeting catenin, Beat-1 (CTNNB1)'20138,314,229'siRNA targeting tie-2'20128,304,528'SiRNA targeting fructose-1, 6-bisphosphatase 1 (FBP1)'20128,293,887'SiRNA targeting beta secretase (BACE)'20128,268,985'siRNA targeting amyloid beta (A4) precursor protein (APP)'20128,247,169'SiRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)'20128,236,942'SiRNA targeting glucagon receptor (GCGR)'20128,232,386'SiRNA targeting apolipoprotein B (APOB)'20128,232,385'siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)'20128,222,395'siRNA targeting kinase insert domain receptor (KDR)'20128,222,396'SiRNA targeting proto-oncogene MET'20128,217,162'siRNA targeting interleukin-1 receptor-associated kinase 4(IRAK4)'20128,198,427'SiRNA targeting catenin, beta-1 (CTNNB1)'20128,138,329'siRNA targeting connective tissue growth factor (CTGF)'20128,071,754'siRNA targeting apolipoprotein B (APOB)'20118,067,576'siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)'20118,039,610'siRNA targeting superoxide dismutase 1 (SOD1)'20118,030,474'siRNA targeting cyclin-dependent kinase 4 (CDK4)'20118,030,476'siRNA targeting gremlin'20118,022,198'siRNA targeting histamine receptor H1'20118,022,199'SiRNA targeting myeloid differentiation primary response gene (88) (MYD88)'20118,013,145'SiRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)'20118,008,474'siRNA targeting KRAS'20117,999,097'siRNA targeting beta secretase (BACE)'20118,000,902'Methods and compositions for selecting siRNA of improved functionality'20117,985,854'siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)'20117,977,471'siRNA targeting TNFα'20117,951,935'siRNA targeting v-myc myelocytomatosis viral oncogene homolog (MYC)'20117,935,813'siRNA target hypoxia-inducible factor 1'20117,897,754'SiRNA targeting ras-related nuclear protein RAN'20117,893,247'siRNA targeting spleen tyrosine kinase'20117,855,186'siRNA targeting TIE-2'20107,833,989'siRNA targeting connective tissue growth factor (CTGF)'20107,829,696'siRNA targeting amyloid beta (A4) precursor protein (APP)'20107,820,809'Functional and hyperfunctional siRNA directed against Bcl-2'20107,816,512'siRNA targeting proto-oncogene MET'20107,807,820'siRNA targeting beta secretase (BACE)'20107,807,819'siRNA targeting survivin'20107,803,933'siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)'20107,795,420'Functional and hyperfunctional siRNA directed against Bcl-2'20107,795,421'siRNA targeting apolipoprotein B (APOB)'20107,781,575'siRNA targeting tumor protein 53 (p53)'20107,745,612'siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)'20107,745,610'siRNA targeting cyclin dependent kinase 11 (CDK11)'20107,745,611'siRNA targeting KRAS'20107,741,470'siRNA targeting gremlin'20107,737,267'siRNA targeting hypoxia-inducible factor 1'20107,709,629'siRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)'20107,696,344'siRNA targeting complement factor B'20107,691,997'Functional and hyperfunctional siRNA'20107,691,998'siRNA targeting nucleoporin 62kDa (Nup62)'20107,678,896'siRNA targeting serine/threonine kinase 12 (STK12 or aurora B kinase)'20107,674,896'siRNA targeting BCL2L1'20107,666,853'siRNA targeting connective tissue growth factor (CTGF)'20107,662,950'siRNA targeting myeloid differentiation primary response gene (88) (MYD88)'20107,655,788'siRNA targeting DNA-damage-inducible transcript 4 (DDIT4)'20107,655,789'siRNA targeting transient receptor potential cation channel, subfamily V, member 1 (TRPV1)'20107,645,869'siRNA targeting spleen tyrosine kinase'20107,645,870'siRNA targeting proteasome 26S subunit, non-ATPase, 10 (Gankyrin or PSMD10)'20107,642,349'siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)'20107,638,621'siRNA targeting insulin-like growth factor 1 receptor (IGF-1R)'20097,638,622'SiRNA targeting intercellular adhesion molecule 1 (ICAM1)'20097,635,770'siRNA targeting protein kinase N-3 (PKN-3)'20097,635,771'siRNA targeting amyloid beta (A4) precursor protein (APP)'20097,632,939'siRNA targeting proto-oncogene MET'20097,632,938'siRNA targeting superoxide dismutase 1 (SOD1)'20097,619,081'siRNA targeting coatomer protein complex, subunit beta 2 (COPB2)'20097,615,541'siRNA targeting TIE-2'20097,612,196'siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)'20097,608,707'siRNA targeting survivin'20097,608,706'siRNA targeting ras-related nuclear protein'20097,605,250'siRNA targeting cAMP-specific phosphodiesterase 4D'20097,605,252'siRNA targeting kinase insert domain receptor (KDR)'20097,598,370'siRNA targeting polo-like kinase-1 (PLK-1)'20097,598,369'siRNA targeting histamine receptor H1'20097,595,388'siRNA targeting EPH receptor A3 (EPHA3)'20097,595,389'siRNA targeting casitas B cell lymphoma-B (CBL-B)'20097,592,442'siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2)'20097,592,444'siRNA targeting myeloid cell leukemia sequence 1'20097,592,443'siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4)'20097,589,191'siRNA targeting hypoxia-inducible factor 1'20097,582,747'siRNA targeting inner centromere protein antigens (INCENP)'20097,582,746'siRNA targeting complement component 3 (C3)'20097,579,458'siRNA targeting synuclein, alpha (SNCA-1)'20097,579,457'siRNA targeting carbonic anhydrase II'20097,576,197'SiRNA targeting KRAS'20097,576,196'siRNA targeting transducin (beta)-like 3 (TBL3)'20097,569,684'siRNA targeting gremlin'20097,550,572'siRNA targeting cell division cycle 20 homolog (CDC20)'20097,541,453'siRNA targeting aquaporin 4'20097,521,191'siRNA targeting connexin 43'20097,514,550'siRNA targeting myeloid cell leukemia sequence 1'20097,507,811'siRNA targeting KRAS'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2013Patents assigned to DHARMACON INC (97)· patent assignee history
2009–2020Based in Denver, CO, US· patent location history
2009–2011Based in Boulder, CO, US· patent location history
2011–2014Patents assigned to LEAKE DEVIN (25)· patent assignee history
2011–2014Patents assigned to MARSHALL WILLIAM (25)· patent assignee history
2011–2014Patents assigned to READ STEVEN (25)· patent assignee history
2011–2014Patents assigned to REYNOLDS ANGELA (25)· patent assignee history
2011Based in Brooklyn, NY, US· patent location history
2017Based in Lafayette, CO, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DHARMACON INC972009–2013
LEAKE DEVIN252011–2014
MARSHALL WILLIAM252011–2014
READ STEVENself252011–2014
REYNOLDS ANGELA252011–2014
Locations
LocationPatentsSpan
Denver, CO, US1072009–2020
Boulder, CO, US52009–2011
Lafayette, CO, US32017
Brooklyn, New York, US12011